The Valley Desk

NCT01537432 · Interventional trial

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Overall registry status Completed

Phase 2

Conditions Psoriasis, Plaque-type Psoriasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov